2754-6993

Schizophrenia

Springer Science and Business Media LLC

View prefix report (10.1038)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 188 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact188 DOIs
2

Attach ORCID iDs across 51 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact51 DOIs
3

Deposit reference lists for 34 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact34 DOIs

DOIs for this ISSN

Showing the top 5 of 569 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 ChatGPT: these are not hallucinations – they’re fabrications… (10.1038/s41537-023-00379-4)
Abstract ORCID
117.02 218
2 Can artificial intelligence be the future solution to the en… (10.1038/s41537-025-00583-4)
Abstract ORCID
66.11 20
3 Glymphatic system dysfunction correlated with gut dysbiosis… (10.1038/s41537-025-00661-7)
Abstract ORCID
61.52 16
4 The role of ferroptosis and oxidative stress in cognitive de… (10.1038/s41537-025-00555-8)
Abstract ORCID
58.80 14
5 Unraveling the heart-brain axis: shared genetic mechanisms i… (10.1038/s41537-024-00533-6)
Abstract ORCID
53.96 11
6 Prevalence of cardiovascular risk factors and disease in pat… (10.1038/s41537-025-00642-w)
Abstract ORCID
52.07 10
7 Transplantation of gut microbiota derived from patients with… (10.1038/s41537-024-00460-6)
ORCID
38.60 34
8 Gut microbiome and schizophrenia: insights from two-sample M… (10.1038/s41537-024-00497-7)
Abstract
36.93 29
9 Bridging cholinergic signalling and inflammation in schizoph… (10.1038/s41537-024-00472-2)
Abstract ORCID
34.95 4
10 Onset age moderates the associations between neutrophil-to-l… (10.1038/s41537-024-00522-9)
Abstract ORCID
34.95 4
11 Changes in kynurenine metabolites in the gray and white matt… (10.1038/s41537-024-00447-3)
ORCID
33.56 21
12 Resting-state brain functional alterations and their genetic… (10.1038/s41537-023-00338-z)
ORCID
30.76 16
13 Capsaicin alleviates neuronal apoptosis and schizophrenia-li… (10.1038/s41537-023-00406-4)
ORCID
30.76 16
14 Variations of blood D-serine and D-aspartate homeostasis tra… (10.1038/s41537-024-00537-2)
Abstract
30.76 16
15 Association between olanzapine concentration and metabolic d… (10.1038/s41537-022-00211-5)
ORCID
30.10 15
16 Intensive longitudinal assessment of mobility, social activi… (10.1038/s41537-023-00383-8)
Abstract ORCID
30.10 3
17 The neutrophil-to-Lymphocyte ratio is associated with clinic… (10.1038/s41537-024-00437-5)
ORCID
30.10 15
18 White matter lipidome alterations in the schizophrenia brain (10.1038/s41537-024-00542-5)
Abstract
29.40 14
19 Heterogeneity of morphometric similarity networks in health… (10.1038/s41537-025-00612-2)
Abstract
29.40 14
20 Face pareidolia in male schizophrenia (10.1038/s41537-022-00315-y)
ORCID
28.65 13
21 Nicotinamide ameliorates mitochondria-related neuronal apopt… (10.1038/s41537-023-00357-w)
ORCID
28.65 13
22 Prevalence and incidence measures for schizophrenia among co… (10.1038/s41537-024-00490-0)
Abstract
28.65 13
23 Prognostic associations of cortical gyrification in minimall… (10.1038/s41537-022-00296-y)
ORCID
27.85 12
24 Smoking affects symptom improvement in schizophrenia: a pros… (10.1038/s41537-024-00449-1)
ORCID
26.98 11
25 The contribution of prosody to machine classification of sch… (10.1038/s41537-024-00463-3)
ORCID
26.98 11
26 Exploring the molecular targets of fingolimod and siponimod… (10.1038/s41537-024-00504-x)
Abstract
26.98 11
27 Real-world healthcare resource utilization, costs, and predi… (10.1038/s41537-024-00509-6)
Abstract
26.98 11
28 Investigation of choroid plexus variability in schizophrenia… (10.1038/s41537-024-00543-4)
Abstract
26.98 11
29 Network hub centrality and working memory performance in sch… (10.1038/s41537-022-00288-y)
ORCID
26.03 10
30 Long-term clinical recovery and treatment resistance in firs… (10.1038/s41537-024-00489-7)
Abstract
26.03 10
31 Glutamine and GABA alterations in cingulate cortex may under… (10.1038/s41537-022-00272-6)
ORCID
25.00 9
32 Do subtle cultural differences sculpt face pareidolia? (10.1038/s41537-023-00355-y)
ORCID
25.00 9
33 Investigating the causal pathways among psychopathological v… (10.1038/s41537-024-00545-2)
Abstract
25.00 9
34 Sample ascertainment and clinical outcome measures in the Ac… (10.1038/s41537-025-00556-7)
Abstract
25.00 9
35 The immediate alteration of cerebellar Glx/GABA and cerebell… (10.1038/s41537-025-00563-8)
Abstract
25.00 9
36 Determinants of patient satisfaction in clozapine users: res… (10.1038/s41537-025-00570-9)
Abstract
25.00 9
37 Author Correction: Persons with first episode psychosis have… (10.1038/s41537-021-00199-4)
Abstract References
23.86 2
38 Convergent and divergent gray matter volume abnormalities in… (10.1038/s41537-022-00261-9)
ORCID
23.86 8
39 Antipsychotics function as epigenetic age regulators in huma… (10.1038/s41537-022-00277-1)
Abstract
23.86 8
40 Harmonizing cross-cultural and transdiagnostic assessment of… (10.1038/s41537-024-00540-7)
Abstract
23.86 8
41 Cognitive assessment in the Accelerating Medicines Partnersh… (10.1038/s41537-025-00578-1)
Abstract
23.86 8
42 An exploratory network analysis to investigate schizotypy’s… (10.1038/s41537-025-00584-3)
Abstract
23.86 8
43 Semantic memory disorganization linked to social functioning… (10.1038/s41537-025-00615-z)
Abstract
23.86 8
44 Association between metabolic syndrome, diabetes mellitus, i… (10.1038/s41537-025-00694-y)
Abstract ORCID
23.86 2
45 Motor dysfunction, social context and early prodromal featur… (10.1038/s41537-025-00704-z)
Abstract ORCID
23.86 2
46 Structural and functional connectivity in relation to execut… (10.1038/s41537-024-00487-9)
Abstract
22.58 7
47 Elevated plasma matrix metalloproteinase 9 in schizophrenia… (10.1038/s41537-024-00494-w)
Abstract
22.58 7
48 The dimensional structure of the Positive and Negative Syndr… (10.1038/s41537-024-00499-5)
Abstract
22.58 7
49 Hierarchical analysis of the sense of agency in schizophreni… (10.1038/s41537-024-00512-x)
Abstract
22.58 7
50 Exploring the potential pharmacological mechanism of aripipr… (10.1038/s41537-024-00523-8)
Abstract
22.58 7